- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 7, 2025 | 181.21M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 69.41M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 62.98M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 58.4M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 58.34M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $11.88M |
| Capex | Q3 2025 · Sep 30, 2024 | $753K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$70.22M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$36.22M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $11.08M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $22.15M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $16.79M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $146.2M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $16.71M |
| Cash And Equivalents restated | Q3 2025 · Sep 30, 2024 | $33.19M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$219.5M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$486.92M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$376.63M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$250.84M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | −$238.17M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | −$220.77M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | −$203.96M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | −$187.1M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $34.65M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $31.22M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $174.16M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $115.75M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $151.83M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $20.25M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $177.84M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $35.56M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$3.89 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$8.13 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.33 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.94 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$3.89 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$8.13 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.33 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.94 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $9.18M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $21.46M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $5.15M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $15.68M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $13.45M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $35.8M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $10.43M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $29.29M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$269.94M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$511.85M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$113.73M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$128.19M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$19.14M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$55.11M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$17.97M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$18M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$29.97M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$73.92M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$18.21M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$52.26M |
| Revenue | Q3 2025 · Sep 30, 2025 | $770K |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.74M |
| Revenue | Q3 2025 · Sep 30, 2024 | $400K |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.23M |